HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-26-2008, 04:58 PM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
important article on a natural flavonoid which causes ubiquinization of her2

ie, it gets it ready for the garbage collector mechanism of the cell which then destroys it. Worth struggling with the big words!:

J Cell Biochem. 2008 Jul 24. [Epub ahead of print]
Quercetin-induced ubiquitination and down-regulation of Her-2/neu.

Jeong JH, An JY, Kwon YT, Li LY, Lee YJ.
Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
Her-2/neu (ErbB2) is a transmembrane tyrosine kinase and acts as a co-receptor for the other EGFR family members. It is well known that high expression of Her-2/neu is associated with a poor prognosis in breast cancer. Quercetin, a flavonoid present in many vegetables and fruits, has been studied extensively as a chemoprevention agent in several cancer models. In this study, we observed that quercetin decreased the level of Her-2/neu protein in time- and dose-dependent manners and also inhibited the downstream survival PI3K-Akt signaling pathway in Her-2/neu-overexpressing breast cancer SK-Br3 cells. We also observed that quercetin induced polyubiquitination of Her-2/neu. When the proteasome pathway was blocked by MG-132 during quercetin treatment, accumulation of the NP-40 insoluble form of Her-2/neu occurred. Interestingly, data from immunocomplex studies revealed that quercetin promoted interaction between Her-2/neu and Hsp90 which is a molecular chaperone involved in stabilization of Her-2/neu. In this condition, inhibition of Hsp90 activity by a specific inhibitor, geldanamycin (GA), or intracellular ATP depletion caused dissociation of Hsp90 from Her-2/neu and promoted ubiquitination and down-regulation of Her-2/neu protein. In addition, the carboxyl terminus of Hsc70-interacting protein (CHIP), a chaperone-dependent E3 ubiquitin ligase, played a crucial role in the quercetin-induced ubiquitination of Her-2/neu. Inhibition of tyrosine kinase activity of Her-2/neu by quercetin could indicate an lateration in the Her-2/neu structure which promotes CHIP recruitments and down-regulation of Her-2/neu. We believe that by using quercetin, new therapeutic strategies can be developed to treat Her-2/neu overexpressing cancers. J. Cell. Biochem. (c) 2008 Wiley-Liss, Inc.
PMID: 18655187 [PubMed - as supplied by publisher

from the conclusions:
Besides quercetin, several other natural products are known to have the effect of down-regulating Her-2/neu protein. Among plant flavonoids, apigenin has a potent growth-inhibitory effect and induces apoptosis in Her-2/neu overexpressing breast cancer cells. Apigenin dissociates Her-2/neu from GRP94 and produces reduction of the intracellular level of Her-2/neu through the ubiquitin-proteasome dependent protein degradation pathway [Way et al., [2004]]. Curcumin, a major pigment extracted from the plant Curcuma longa Lin, covalently modifies Her-2/neu and induces CHIP-dependent ubiquitination, but curcumin induces Her-2/neu depletion other than by the proteasomal degradation pathway [Jung et al., [2007]]. Oleic acid (OA; 18:1n-9), the main monounsaturated fatty acid of olive oil, is known to suppress the overexpression of Her-2/neu. In contrast to quercetin, OA exposure specifically represses the transcriptional activity of the Her-2/neu gene promoter; this is due to the up-regulation of the Ets protein PEA3 (a transcriptional repressor of the Her-2/neu gene promoter) by OA [Menendez et al., [2005]]. Compared to these other natural compounds, quercetin induces Her-2/neu down-regulation in a unique manner.

In the treatment of Her-2/neu overexpressing breast cancers, there are two major approaches to targeting Her-2/neu: down-regulation of Her-2/neu protein level using ectodomain-binding antibodies (mAbs) and inhibition of tyrosine kinase activity by small molecule inhibitors that compete with ATP in the tyrosine kinase domain [Imai and Takaoka, [2006]]. In this report, we revealed that quercetin inhibits Her-2/neu tyrosine kinase activity (Fig. 7A-C) and down-regulates Her-2/neu protein level (Fig. 1). It is interesting that the manner in which quercetin down-regulates Her-2/neu protein is very similar to that of the CI-1033 tyrosine kinase inhibitor [Citri et al., [2002]]. Along with inhibition of tyrosine phosphorylation, CI-1033 enhances ubiquitylation and accelerates endocytosis and subsequent intracellular degradation of Her-2/neu protein. The degradative pathway stimulated by tyrosine kinase inhibitors appears to be chaperone mediated. Similar to quercetin and GA, CI-1033 and GA additively inhibit tumor cell growth [Citri et al., [2002]]. We believe that, as shown in the study of CI-1033, an understanding of the dual inhibitory function of quercetin advances clinical application, allowing effective therapeutic and preventive studies to be initiated.
Lani is offline   Reply With Quote
Old 07-26-2008, 05:19 PM   #2
Joan M
Senior Member
 
Joan M's Avatar
 
Join Date: Oct 2007
Posts: 1,851
Lani,

Sloan-Kettering is conducting an anti-heat shock protein 90 study (CNF2024). An oncologist there suggested the trial to me.

Joan
__________________
Diagnosed stage 2b in July 2003 (2.3 cm, HER2+, ER-/PR-, 7+ nodes). Treated with mastectomy (with immediate DIEP flap reconstruction), AC + T/Herceptin (off label). Cancer advanced to lung in Jan. 2007 (1 cm nodule). Started Herceptin every 3 weeks. Lung wedge resection April 2007. Cancer recurred in lung April 2008. RFA of lung in August 2008. 2nd annual brain MRI in Oct. 2008 discovered 2.6 cm cystic tumor in left frontal lobe. Craniotomy Oct. 2008 (ER-/PR-/HER2-) followed by targeted radiation (IMRT). Coughing up blood Feb. 2009. Thoractomy July 2009 to cut out fungal ball of common soil fungus (aspergillus) that grew in the RFA cavity (most likely inhaled while gardening). No cancer, only fungus. Removal of tiny melanoma from upper left arm, plus sentinel lymph node biopsy in Feb. 2016. Guardant Health liquid biopsy in Feb. 2016 showed mutations in 4 subtypes of TP53. Repeat of Guardant Health biopsy in Jana. 2021 showed 3 TP53 mutations, BRCA1 mutation and CHEK2 mutation. Invitae genetic testing showed negative for all of these. Living with MBC since 2007. Stopped Herceptin Hylecta (injection) treatment in March 2020. Recent 2021 annual CT of chest, abdomen and pelvis and annual brain MRI showed NED. Praying for NED forever!!
Joan M is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 07:31 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter